DORTIQ

Welcome to the Brand page for “DORTIQ”, which is offered here for Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, osteoarthritis, bursitis, fibrotic diseases, and infections;sustained drug delivery systems for pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “DORTIQ” is believed to be currently owned by “EYEPOINT PHARMACEUTICALS US, INC.”